Land and climate are strongly connected through multiple interface processes and climate change may lead to significant changes in land use. In this study, high-resolution observational gridded datasets are used to assess modifications in the Köppen-Geiger and Worldwide Bioclimatic (WBCS) Classification Systems, from 1950‒1979 to 1990‒2019 in Portugal. A compound Bioclimatic-Shift Exposure Index (BSEI) is also defined to identify the most exposed regions to recent climatic changes. The temporal evolution of land cover with vineyards and olive groves between 1990 and 2018, as well as correlations with areas with bioclimatic shifts, are analyzed. Results show an increase (decrease) of CSa Warm Mediterranean climate with hot summer (CSb, warm summer) of 18.1% (‒17.8%). The WBCS Temperate areas also reveal a decrease of ‒5.11%. Arid and semi-arid ombrotypes areas increased, conversely to humid to sub-humid ombrotypes. Thermotypic horizons depict a shift towards warmer classes. BSEI highlights the most significant shifts in northwestern Portugal. Vineyards have been displaced towards regions that are either the coolest/humid, in the northwest, or the warmest/driest, in the south. For oliviculture, the general trend for a relative shift towards cool/humid areas suggests an attempt of the sector to adapt, despite the cover area growth in the south. As vineyards and olive groves in southern Portugal are commonly irrigated, options for the intensification of these crops in this region may threaten the already scarce water resources and challenge the future sustainability of these sectors.

The diagnosis and the pathology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) remain under debate. However, there is a growing body of evidence for an autoimmune component in ME/CFS caused by the Epstein-Barr virus (EBV) and other viral infections. In this work, we took advantage of a large public dataset on the IgG antibodies to 3,054 EBV peptides to understand whether these immune responses could be used as putative biomarkers for disease diagnosis and triggers of pathological autoimmunity in ME/CFS patients using healthy controls (HCs) as a comparator cohort. We then aimed at predicting disease status of study participants using a Super Learner algorithm targeting an accuracy of 85% when splitting data into train and test datasets. When we compared data of all ME/CFS patients or data of a subgroup of these patients with non-infectious or unknown disease trigger to the dataset of HC, we could not find an antibody-based classifier that would meet the desired accuracy in the test dataset. In contrast, we could identify a 26-antibody classifier that could distinguish ME/CFS patients with an infectious disease trigger from HCs with 100% and 90% accuracies on the train and test sets, respectively. We finally performed a bioinformatic analysis of the EBV peptides associated with these 26 antibodies. We found no correlation between the importance metric of the selected antibodies in the classifier and the maximal sequence homology between human proteins and each EBV peptide recognized by these antibodies. In conclusion, these 26 antibodies against EBV have an effective potential for disease diagnosis of a subset of patients, but they are less likely to trigger pathological autoimmune responses that could explain the pathogenesis of ME/CFS.